Protected: OncoBeta’s CEO and Managing Director Shannon D. Brown III talks about its innovative non-invasive skin cancer treatment Rhenium-SCT®
This content is password-protected. To view it, please enter the password below. Password:
Browsing: Featured
Whole exome sequencing predicts whether patients respond to cancer immunotherapy
Immunotherapies, such as immune checkpoint inhibitors, have transformed the treatment of advanced stage cancers. Unlike…
New material for surgical dressings shown to prevent recurrence of melanoma and enhance healing
A new type of dressing for post-surgical treatment of melanoma has been created by scientists…
Oral bacteria could offer innovative clues for pancreatic cancer growth and treatment
Pancreatic cancer is the sixth leading cause of cancer deaths worldwide. Because of limited screening…
Less scroll time, more screen time
Cancer Council and the Australian Government urge Australians to Get2it and do the bowel screening test Australia’s bathroom…
Hereditary factors that increase the likelihood of cancer mutations detailed in new study
Mutations occur in various tissues and organs of an individual. Somatic mutations occur in cells…
Teletrials right on target
When it comes to cancer care, all things are not equal. That’s especially true for…
Lipid nanoparticles carry gene-editing cancer drugs past tumour defenses
As they grow, solid tumours surround themselves with a thick, hard-to-penetrate wall of molecular defences.…
Liquid biopsy detects DNA markers in advanced breast cancer within five hours
A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer…
A crystal ball in the fight against oesophageal cancer
Biomarkers are like the X on a treasure map, but instead of indicating the location…